Tiziana Life Sciences Gets $3.4 Million in Funding for Neurodegenerative Disease Studies

MT NewswiresJun 29 00:29

Express News | Tiziana Receives $3.4 Million in Non-Dilutive Funding

BreakingsJun 28 23:02

Press Release: Tiziana Receives $3.4 Million in Non-Dilutive Funding

Dow JonesJun 28 23:01

Express News | Tiziana Life Sciences Ltd: To Dose First Patient With Moderate Alzheimer's Disease With Foralumab

BreakingsJun 26 19:05

Express News | Tiziana Life Sciences: FDA Has Allowed Intranasal Foralumab to Be Used Under Expanded Access Ind in First Patient With Moderate Alzheimer S Disease

BreakingsJun 26 19:02

Tiziana Life Sciences to Dose First Patient With Moderate Alzheimer's Disease With Foralumab

GlobeNewswireJun 26 19:00